Literature DB >> 2129906

In vitro models of B lymphocyte development.

A J Henderson1, K Dorshkind.   

Abstract

B lymphocyte differentiation proceeds in the bone marrow in association with a supporting framework of stromal cells. The various long-term bone marrow cultures have provided valuable in vitro models for the study of both normal and dysregulated, stromal cell dependent B lymphopoiesis. Stromal cell lines have been cloned from the adherent layers of the cultures, and recent studies indicate these cells produce soluble factors that control the growth and differentiation of B lineage cells. Modifications of the long-term cultures are now being developed that permit specific stages in the B cell developmental pathway to be amplified. These systems should prove valuable for analysis of stromal cell derived signals that regulate the growth and differentiation of B lineage cells.

Mesh:

Substances:

Year:  1990        PMID: 2129906

Source DB:  PubMed          Journal:  Semin Immunol        ISSN: 1044-5323            Impact factor:   11.130


  4 in total

1.  BCR-ABL and v-abl oncogenes induce distinct patterns of thymic lymphoma involving different lymphocyte subsets.

Authors:  S S Clark; E Chen; M Fizzotti; O N Witte; V Malkovska
Journal:  J Virol       Date:  1993-10       Impact factor: 5.103

Review 2.  Engineering approaches for regeneration of T lymphopoiesis.

Authors:  Kyung-Ho Roh; Krishnendu Roy
Journal:  Biomater Res       Date:  2016-06-29

3.  Immunosuppression in Experimental Chagas Disease Is Mediated by an Alteration of Bone Marrow Stromal Cell Function During the Acute Phase of Infection.

Authors:  Uwe Müller; Günter A Schaub; Horst Mossmann; Gabriele Köhler; Rita Carsetti; Christoph Hölscher
Journal:  Front Immunol       Date:  2018-12-10       Impact factor: 7.561

4.  Establishment of an in vitro system representing the chicken gut-associated lymphoid tissue.

Authors:  Noorjahan Banu Alitheen; Susan Jane McClure; Swee Keong Yeap; Ye Wen Kristeen-Teo; Sheau Wei Tan; Peter McCullagh
Journal:  PLoS One       Date:  2012-11-19       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.